Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Recombinant interleukin-3 expression system in E. coli].

S V Lutsenko, A I Gurevich, L R Ptitsyn

    Bioorganicheskaia Khimiia
    |March 1, 1992
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Reconstruction of total portosystemic shunt into selective portosystemic shunt in a child].

    Khirurgiia·2023
    Same author

    Evaluation of the Effectiveness of Systemic Therapy of Spinal Cord Injury of Moderate Severity with Human Umbilical Cord Placental Blood Mononuclear Cells Using Indicators of Dispersion of Articular Angles in the Swimming Test.

    Bulletin of experimental biology and medicine·2023
    Same author

    Exact Off Shell Sudakov Form Factor in N=4 Supersymmetric Yang-Mills Theory.

    Physical review letters·2023
    Same author

    A Method of Assessment of the Motor Function of Hind Limbs by Swim Test in Spinal Cord Injury Models.

    Bulletin of experimental biology and medicine·2022
    Same author

    Biological Activity of Agaricinic Acid Nanoparticles against Human Hepatoma HepG2 Cells.

    Bulletin of experimental biology and medicine·2020
    Same author

    Comparison of the Efficiency of Systemic and Local Cell Therapy with Human Umbilical Cord Blood Mononuclear Cells in Rats with Severe Spinal Cord Injury.

    Bulletin of experimental biology and medicine·2020

    Researchers developed an efficient method for producing recombinant human interleukin-3 (hIL3) in E. coli. This involved constructing a new plasmid and optimizing bacterial strains for high-yield protein synthesis and purification.

    Area of Science:

    • Molecular Biology
    • Biotechnology
    • Protein Expression

    Background:

    • Recombinant protein production is crucial for therapeutic applications.
    • Optimizing expression systems in bacterial hosts like E. coli is essential for efficient protein synthesis.
    • Human interleukin-3 (hIL3) is a key cytokine with therapeutic potential.

    Purpose of the Study:

    • To construct and characterize a novel expression plasmid for human interleukin-3 (hIL3).
    • To compare the efficiency of constitutive versus induced biosynthesis of recombinant hIL3 in various E. coli strains.
    • To develop an effective method for isolating, purifying, and renaturing recombinant hIL3 from inclusion bodies.

    Main Methods:

    • Construction of the pTOTE2IL3 (III) plasmid for induced hIL3 expression.

    Related Experiment Videos

  • Comparative analysis of hIL3 protein synthesis levels in different E. coli strains using constitutive (pTE2IL3 (I)) and induced (pTOTE2IL3 (III)) expression systems.
  • Development of a streamlined protocol for the isolation, purification, and renaturation of recombinant hIL3 from bacterial inclusion bodies.

    • Main Results:

    • Successful construction of the pTOTE2IL3 (III) expression plasmid.
    • Identification of optimal combinations of expression plasmids and E. coli strains for enhanced recombinant hIL3 production.
    • Establishment of a simple and effective method for obtaining purified and biologically active recombinant hIL3.

    Conclusions:

    • The developed expression system and purification protocol provide an efficient means for producing recombinant hIL3.
    • Optimization of plasmid and bacterial strain selection is critical for maximizing recombinant protein yield.
    • The method facilitates the production of functional hIL3 for potential therapeutic or research applications.